SCHEDULE 13D

Company

CORCEPT THERAPEUTICS INC

Filed

February 16, 2010

Accession Number

0001193125-10-032316

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →